A Biogen corporate meeting held in Boston in March that was initially connected to about 100 cases of COVID-19 could have led to a significantly higher number of infections. A new study suggests the meeting could have contributed to about 20,000 cases across four Massachusetts counties.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,